ORGO - Organogenesis Holdings Inc.
Organogenesis Holdings Inc. , a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, and cytokines; NuShield, a wound covering tissue includes both amnion and chorion membranes for spongy/intermediate layer intact; PuraPly , a antimicrobial barrier that enables conformability and fluid drainage; and Novachor, an amniotic membrane wound covering in which viable cells, growth factors/cytokines, and ECM proteins are preserved.
As of May 15, 2026: spot at $2.42, ATM IV 149.5%, max pain $2.50, net GEX $24.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Market Cap
- $347.4M
- Beta
- 1.31
- 52-Week Range
- 2.04-7.077
- CEO
- Gary S. Gillheeney
- Employees
- 869
- IPO Date
- Jan 5, 2017
- Exchange
- NASDAQ
What ORGO Looks Like to Options Traders Today
IV rank of 27.6% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); positive net gamma exposure ($24) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes.
What This Page Covers
The ORGO overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked ORGO overview questions
- What is ORGO?
- ORGO is the ticker symbol for Organogenesis Holdings Inc., a listed security. Organogenesis Holdings Inc. , a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. Listed on NASDAQ. ORGO is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the ORGO options snapshot look like today?
- As of May 15, 2026, the ORGO options snapshot shows spot at $2.42, ATM IV 149.5%, IV rank 27.6%, max pain $2.50, net GEX $24, expected move 42.86%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are ORGO's key statistics?
- Organogenesis Holdings Inc. (ORGO) carries a market capitalization of $347.4M, beta of 1.31 relative to the broader market, 52-week range of 2.04-7.077. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does ORGO belong to?
- Organogenesis Holdings Inc. operates in the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare ORGO's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the ORGO data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).